Financial Strategies Acquisition Corp. (FXCO) to Combine with Austin Biosciences in $166M Deal
Financial Strategies (NASDAQ:FXCO) has entered into a definitive agreement to combine with pharmaceutical company Austin Biosciences Corp with a post-deal market capitalization of $166.3 million. The Austin, Minnesota-based company is developing preclinical drug candidates that could potentially improve upon existing cancer treatments. The combined company is expected to trade on the Nasdaq under the symbolRead More
To access this post, you must purchase 1 - User: Monthly Plan.